2x founder

Maddalena Adorno

Investments in innovation | Co-founder @ Dorian Therapeutics (acquired by Altos Lab) | Stanford University | YC | TedX Speaker

Co-founder

2026Operating Partner· BioInnovation Institute (BII)

Founder · since 2014

Company

BioInnovation Institute (BII)

Role

Operating Partner

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Profile coverage5 of 7 · missing posts, contact

Dorian Therapeutics

New therapeutics to rejuvenate tissue and treat age-related diseases

Experience

Career

BioInnovation Institute (BII)
Operating Partner · 2026 – Present
2026
Dorian Therapeutics
Co-founder
Co-Founder and CEO · San Francisco Bay Area · 2018 – Present
2018
Stanford Continuing Studies
Instructor · Stanford, California, United States · 2021 – Present
2021
StartX.
Member S19 · Palo Alto, CA · 2019 – Present
2019
Nuraxi Holdings, Inc.
Board Member and Scientific Advisor · 2023 – Present
2023
Stanford University School of Medicine
Research Scientist · 2014 – 2018
2014
Stanford University School of Medicine
Siebel Scholar · 2014 – 2015
2014
Stanford University School of Medicine
Post-doc in Stem Cells and Cancer Stem Cells · 2009 – 2014
2009
StemGuard Therapeutics Inc.
Co-founder
Scientific Co-Founder · 2014 – 2017
2014